Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jiahua Pharmaceutical Technology is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of innovative small molecule drugs. The company operates an integrated R&D platform that supports both its internal pipeline and its activities as a CRO and CDMO provider. Jiahua's research focus includes oncology, metabolic diseases, and inflammatory conditions, with lead programs targeting EGFR mutations and URAT1. By leveraging expertise in medicinal chemistry and process development, the company aims to deliver high-quality therapeutic candidates to address significant unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiahua Pharmaceutical Technology.